Execs hail ‘merger of equals’ in Supernus, Indivior deal

AI Briefing

• – Supernus Pharma and Indivior agree to merge in 'merger of equals' deal.
• – Financial terms of the deal have not been disclosed.
• – The deal is expected to close in 2027.